Novavax
NVAX
237 hedge funds and large institutions have $1.19B invested in Novavax in 2024 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 32 closing their positions.
28% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 32
12% more capital invested
Capital invested by funds: $1.06B → $1.19B (+$126M)
3% more funds holding
Funds holding: 229 → 237 (+8)
3% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 65
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.9% less ownership
Funds ownership: 59.5% → 58.6% (-0.9%)
25% less call options, than puts
Call options by funds: $124M | Put options by funds: $164M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$20.9M |
| 2 |
Millennium Management
New York
|
+$19.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.5M |
| 4 |
SG Americas Securities
New York
|
+$13.5M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Voloridge Investment Management
Jupiter,
Florida
|
-$22.4M |
| 2 |
Goldman Sachs
New York
|
-$6.73M |
| 3 |
Coatue Management
New York
|
-$5.17M |
| 4 |
D.E. Shaw & Co
New York
|
-$4.97M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.66M |
NVAX Hedge Fund Activity: Q3 2024 in Review
237 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2024, worth a combined $1.19B — up 12% from $1.06B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NVAX positions and 32 closed out — a net gain of 9 holders — while 67 added to existing stakes and 65 trimmed.
The largest buyer was State Street, adding an estimated $20.9M. The largest seller was Voloridge Investment Management, cutting an estimated $22.4M.
- 237 institutional investors held Novavax (NVAX) as of Q3 2024, up from 229 in Q2 2024.
- Funds reported $1.19B of Novavax stock for Q3 2024, up 12% quarter-over-quarter.
- 41 funds opened new Novavax positions in Q3 2024 and 32 closed out, a net change of +9 holders.
- The largest Novavax buyer in Q3 2024 was State Street, an estimated $20.9M added.
- The largest Novavax seller in Q3 2024 was Voloridge Investment Management, an estimated $22.4M sold.
Based on aggregated 13F filings for Q3 2024.